What you might feel: Mild appetite reduction, sometimes barely noticeable Slight nausea in the first 24-48 hours after injection, typically resolving quickly Occasional changes in bowel habits Some people feel nothing at all, and that is completely normal at this dose What you should not feel: Severe nausea or vomiting (may indicate a dosing error, double-check your unit calculation ) Complete loss of appetite (unusual at 2.5 mg) Significant weight loss (possible but not typical at the initiation dose) Do not increase your dose before completing four full weeks at 2.5 mg
Our team verifies your benefits to establish if Wegovy or other semaglutide brands are covered and fully handles the prior authorization, saving you time and hassle
LGSOC and CCOC), and thus we observed some wide confidence intervals for some of the MR estimates
Alternatively, make your timing switch first while staying at your current dose, stabilize for 2 weeks, then escalate the dose
GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes and weight management